Published in J Behav Med on June 01, 1981
The influence of caloric information on cafeteria food choices. J Appl Behav Anal (1984) 2.04
Do weight loss and adherence cluster within behavioral treatment groups? Obesity (Silver Spring) (2013) 1.83
Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity. Diabetes Metab Syndr Obes (2013) 0.82
Obstructive sleep apnea and body weight. Chest (1984) 0.82
A Management Guideline for Obesity-Hypoventilation Syndromes. Sleep Breath (1999) 0.81
A randomized controlled trial testing an Internet delivered cost-benefit approach to weight loss maintenance. Prev Med (2016) 0.80
Behavioral obesity research: Where have all the single subjects gone? Behav Anal (1988) 0.75
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med (2001) 7.51
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation (1997) 4.41
Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA (1999) 3.56
A molecular theory of lipid-protein interactions in the plasma lipoproteins. FEBS Lett (1974) 3.43
Serum cholesterol. Doing the right thing. Circulation (1993) 3.16
Why treatments for obesity don't last. J Am Diet Assoc (1991) 2.68
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb (1992) 2.31
Digital imaging fluorescence microscopy: spatial heterogeneity of photobleaching rate constants in individual cells. J Cell Biol (1985) 2.20
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation (1986) 2.06
Lipoprotein structure and metabolism. Physiol Rev (1976) 2.04
Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. Biochemistry (1973) 1.81
Lipoproteins: structure and function. Annu Rev Biochem (1975) 1.76
Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ Res (2001) 1.74
Relation of diet to high-density-lipoprotein cholesterol in middle-aged marathon runners, joggers, and inactive men. N Engl J Med (1980) 1.72
Introduction to the plasma lipoproteins. Methods Enzymol (1986) 1.71
Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I. J Clin Invest (1978) 1.69
Human plasma lipoprotein [a]. Structural properties. J Biol Chem (1983) 1.68
Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase. Biochemistry (1975) 1.66
Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb (1993) 1.65
Accuracy and precision of analyses for total cholesterol as measured with the Reflotron cholesterol method. Clin Chem (1989) 1.60
Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J Lipid Res (2000) 1.57
The plasma lipoproteins: structure and metabolism. Annu Rev Biochem (1978) 1.54
Health family trees: a tool for finding and helping young family members of coronary and cancer prone pedigrees in Texas and Utah. Am J Public Health (1988) 1.53
Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci U S A (1978) 1.53
Weighing the options: criteria for evaluating weight-management programs. The Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity. Obes Res (1995) 1.52
AHA consensus panel statement. Preventing heart attack and death in patients with coronary disease. The Secondary Prevention Panel. J Am Coll Cardiol (1995) 1.52
The primary structure of human apolipoprotein A-IV. Biochim Biophys Acta (1989) 1.50
The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol (2000) 1.46
Challenges in obesity management. South Med J (1998) 1.45
Plasma lipid and lipoprotein response of humans to beef fat, coconut oil and safflower oil. Am J Clin Nutr (1985) 1.45
Obesity is an environmental issue. Atherosclerosis (1999) 1.44
Long-term follow-up of weight status of subjects in a behavioral weight control program. J Am Diet Assoc (1989) 1.42
Risk reduction. Circulation (2000) 1.42
An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction. Am J Cardiol (1991) 1.42
Scientific and legal issues in fenfluramine/dexfenfluramine litigation. Tex Med (2000) 1.42
Communication patterns in a biomedical research center. J Med Educ (1978) 1.42
A prospective study of genetic markers of susceptibility to infection and inflammation, and the severity, progression, and regression of coronary atherosclerosis and its response to therapy. J Mol Med (Berl) (2000) 1.42
Kinetics of lipid--protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines. Biochemistry (1978) 1.41
Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA (1989) 1.40
On the protein defect in abetalipoproteinemia. N Engl J Med (1971) 1.40
The cyanogen bromide peptides of the apoprotein of low density lipoprotein (ApoB): its molecular weight from a chemical view. Biochem Biophys Res Commun (1978) 1.39
The complete cDNA and amino acid sequence of human apolipoprotein B-100. J Biol Chem (1986) 1.39
Preventing heart attack and death in patients with coronary disease. Circulation (1995) 1.36
Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc Natl Acad Sci U S A (1983) 1.36
The human apolipoprotein B-100 gene: a highly polymorphic gene that maps to the short arm of chromosome 2. Biochem Biophys Res Commun (1985) 1.36
Molecular cloning and expression of partial cDNAs and deduced amino acid sequence of a carboxyl-terminal fragment of human apolipoprotein B-100. Proc Natl Acad Sci U S A (1985) 1.35
Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein C-II. Proc Natl Acad Sci U S A (1977) 1.35
Effects of saturated and polyunsaturated fat diets on the chemical composition and metabolism of low density lipoproteins in man. J Lipid Res (1980) 1.30
The black American lifestyle intervention (BALI): the design of a weight loss program for working-class African-American women. J Am Diet Assoc (1994) 1.30
Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials. Int J Obes Relat Metab Disord (2002) 1.29
Three-dimensional structure of low density lipoproteins by electron cryomicroscopy. Proc Natl Acad Sci U S A (1999) 1.29
Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J Clin Invest (1984) 1.29
The structure of the human apolipoprotein C-II gene. Electron microscopic analysis of RNA:DNA hybrids, complete nucleotide sequence, and identification of 5' homologous sequences among apolipoprotein genes. J Biol Chem (1985) 1.28
Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages. J Clin Invest (1982) 1.27
A comparative study on the removal of cellular lipids from Landschütz ascites cells by human plasma apolipoproteins. J Biol Chem (1975) 1.27
Family versus individually oriented intervention for weight loss in Mexican American women. Public Health Rep (1992) 1.25
Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B. Arteriosclerosis (1985) 1.25
Structure of apolipoprotein B-100 of human low density lipoproteins. Arteriosclerosis (1989) 1.24
Lipid-protein interactions in the plasma lipoproteins. Biochim Biophys Acta (1977) 1.23
Reconstituted low density lipoprotein: a vehicle for the delivery of hydrophobic fluorescent probes to cells. J Supramol Struct (1979) 1.23
Kinetics of lipid--protein interactions: effect of cholesterol on the association of human plasma high-density apolipoprotein A-I with L-alpha-dimyristoylphosphatidylcholine. Biochemistry (1979) 1.23
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS): efficacy and tolerability of long-term treatment with lovastatin in women. J Womens Health Gend Based Med (2001) 1.22
The primary structure of human plasma high density apolipoprotein glutamine I (ApoA-I). II. The amino acid sequence and alignment of cyanogen bromide fragments IV, III, and I. J Biol Chem (1975) 1.22
Evaluation of a culturally appropriate intervention to increase physical activity. Am J Health Behav (2001) 1.22
Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins. J Biol Chem (1984) 1.22
Apolipoprotein E mediates uptake of Sf 100-400 hypertriglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblasts. J Biol Chem (1983) 1.17
Primary structure of very low density apolipoprotein C-II of human plasma. Proc Natl Acad Sci U S A (1977) 1.16
Evidence for success of behavior modification in weight loss and control. Ann Intern Med (1993) 1.16
Blood pressure and symptoms of depression and anxiety: a prospective study. Am J Hypertens (2001) 1.16
Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation (1996) 1.16
Measurement and prediction of the rates of spontaneous transfer of phospholipids between plasma lipoproteins. Biochim Biophys Acta (1984) 1.15
Consent for genetics studies among clinical trial participants: findings from Action for Health in Diabetes (Look AHEAD). Clin Trials (2006) 1.15
Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins. Atherosclerosis (1999) 1.14
Nondieting versus dieting treatment for overweight binge-eating women. J Consult Clin Psychol (1998) 1.14
Comparison of 2-year weight loss trends in behavioral treatments of obesity: diet, exercise, and combination interventions. J Am Diet Assoc (1996) 1.14
Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase. J Clin Invest (1984) 1.14
Blood cholesterol screening in several environments using a portable, dry-chemistry analyzer and fingerstick blood samples. Lipid Research Clinics Cholesterol Screening Study Group. Am J Cardiol (1990) 1.13
Evidence for the identity of the major apoprotein in low density and very low density lipoproteins in normal subjects and patients with familial hyperlipoproteinemia. J Clin Invest (1972) 1.13
Psychological correlates of weight fluctuation. Int J Eat Disord (1995) 1.12
Interactions of the major risk factors for coronary heart disease. Am J Med (1986) 1.12
Studies on the protein defect in Tangier disease. Isolation and characterization of an abnormal high density lipoprotein. J Clin Invest (1972) 1.12
Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production. J Biol Chem (1994) 1.11
Murine macrophage tumors are a source of a 260,000-dalton acetyl-low density lipoprotein receptor. J Biol Chem (1985) 1.11
Structure of the dimyristoylphosphatidylcholine vesicle and the complex formed by its interaction with apolipoprotein C-III: X-ray small-angle scattering studies. Biochemistry (1979) 1.10
Effects of insulin on lipoprotein secretion in rat hepatocyte cultures. The role of the insulin receptor. J Biol Chem (1986) 1.10
Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy. Circulation (1999) 1.10
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin. Am J Cardiol (2001) 1.10
The primary structure of high density apolipoprotein-glutamine-I. Proc Natl Acad Sci U S A (1974) 1.09
Metabolism of normal and modified low-density lipoproteins by macrophage cell lines of murine and human origin. Biochim Biophys Acta (1985) 1.09
The influence of lipid on the conformation of human plasma high density apolipoproteins. J Biol Chem (1972) 1.08
Apolipoprotein A-IV. A determinant for binding and uptake of high density lipoproteins by rat hepatocytes. J Biol Chem (1986) 1.08
High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest (1987) 1.07
Triglyceride: the forgotten risk factor. Circulation (1998) 1.06